Silver Spring, Maryland–(ENEWSPF)–April 17, 2017. Standard Homeopathic Company is recalling all lots of Hyland’s Baby Teething Tablets and Hyland’s Baby Nighttime Teething Tablets sold in retail stores to the consumer level. The U.S. Food & Drug Administration (FDA) has concluded that the medicines have been found to contain inconsistent amounts[Read More…]
Day: April 17, 2017
Handbags for Homes 2017 to Be Held on Thursday, June 22
CHICAGO—(ENEWSPF)—April 17, 2017. Join All Chicago on Thursday, June 22, at 6 p.m. at the Woman’s Athletic Club, 626 North Michigan Avenue in Chicago for ‘Handbags for Homes 2017.’ ‘Handbags for Homes 2017’ will be a fun night of fashion, food, friends, while preventing and ending homelessness in Chicago. All are invited[Read More…]
Unitarian Universalist Community Church of Park Forest to Screen Documentary ‘Fix It – Healthcare At The Tipping Point’ on Friday, April 28
Park Forest, IL—(ENEWSPF)—April 17, 2017. The Unitarian Universalist Community Church of Park Forest (UUCCPF), 70 Sycamore Drive in Park Forest, will screen the documentary film ‘ Fix It – Healthcare At The Tipping Point’ on Friday, April 28 at 7 p.m. A discussion will follow the film screening. This documentary[Read More…]
Presentation on the Power of a Plant-Based Diet, Thursday, April 27
HOMEWOOD—(ENEWSPF)—April 17, 2017. The Cancer Support Center and Vegging Out invite you to explore the power of a plant-based diet. The event will take place on Thursday, April 27 beginning at 6:30 p.m. at the Cancer Support Center, 2018 Elm Street in Homewood. The presentation will be given by Nutrition[Read More…]
Rates of New Diagnosed Cases of Type 1 and Type 2 Diabetes on the Rise Among Children, Teens
Fastest rise seen among racial/ethnic minority groups Atlanta, GA–(ENEWSPF)–April 17, 2017. Rates of new diagnosed cases of type 1 and type 2 diabetes are increasing among youth in the United States, according to a report, Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012, published in the[Read More…]
FDA Approves First Drug to Treat Tardive Dyskinesia
Silver Spring, Maryland–(ENEWSPF)–April 17, 2017. The U.S. Food and Drug Administration approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition. Tardive dyskinesia is a neurological disorder characterized by repetitive involuntary movements, usually of the jaw, lips and[Read More…]